Skip to main content
Industry News
Administration backs away from drug rebate rule

The Trump administration is withdrawing a proposal to overhaul drug rebates in Medicare and Medicaid as part of efforts to lower prescription drug costs after "careful analysis and thorough consideration," according to White House spokesman Judd Deere. The administration remains focused on other ideas to manage prescription drug costs, such as tying prices to those in other countries and potentially an inflation cap.

Full Story: